Press release
NRAS, HRAS, and KRAS Market to Reach USD 14.1 Billion by 2034, Growing at a CAGR of 9.2%
NRAS, HRAS, and KRAS Market
Introduction:
Exactitude Consultancy's latest market research report on the NRAS, HRAS, and KRAS Market forecasts substantial growth from USD 6.5 billion in 2024 to USD 14.1 billion by 2034, growing at a CAGR of 9.2%. This growth is driven by advancements in targeted therapies for cancer, expanding applications in drug discovery, and increasing research investments in molecular oncology.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72672
Key Market Stats & Insights:
• Market Size (2024): USD 6.5 Billion
• Market Size (2034): USD 14.1 Billion
• CAGR (2025-2034): 9.2%
• Key Segments:
o By Product Type: Biologics, Small Molecule Inhibitors
o By Application: Cancer Treatment, Genetic Research, Drug Discovery
o By End-User: Pharmaceutical Companies, Research Institutions, Hospitals
o By Technology: Targeted Therapy, Gene Therapy
o By Distribution Channel: Online Pharmacy, Retail Pharmacy
• Largest Region: North America
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72672/nras-hras-and-kras-market
Market Segmentation:
1. By Product Type: Biologics are leading the market, followed by small molecule inhibitors for targeted therapies in cancer.
2. By Application: Cancer treatment leads the market, with increasing demand for KRAS inhibitors and ongoing research into NRAS and HRAS-related therapies.
3. By Region: North America leads the market, driven by a high number of clinical trials and advanced healthcare infrastructure.
Recent Developments in the Market:
• Increased clinical trials focusing on NRAS, HRAS, and KRAS mutations are driving innovation in molecular targeted therapies.
• Biopharmaceutical companies are focusing on the development of novel small molecule inhibitors targeting these mutations to improve cancer treatment outcomes.
Expert Quote:
"The NRAS, HRAS, and KRAS Market is growing rapidly, driven by advancements in targeted cancer therapies and expanding research in molecular oncology," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72672
Key Drivers and Restraints:
• Drivers: Growing prevalence of cancer, increasing research investments, and advancements in gene therapy technologies.
• Restraints: High cost of treatment and challenges in achieving regulatory approval for novel therapies.
Market Forecast (2024-2034):
The NRAS, HRAS, and KRAS Market is projected to grow at a CAGR of 9.2%, reaching USD 14.1 billion by 2034, driven by innovations in cancer therapies and drug discovery processes.
Conclusion:
The NRAS, HRAS, and KRAS Market is poised for significant growth, presenting new opportunities for pharmaceutical companies, research institutions, and oncology-focused healthcare providers to address unmet needs in cancer treatment.
This report is also available in the following languages : Japanese (NRAS、HRAS、KRAS市場), Korean (NRAS、HRAS、KRAS시장), Chinese (NRAS、HRAS、KRAS시장), French (Marché NRAS, HRAS et KRAS), German (NRAS-, HRAS- und KRAS-Markt), and Italian (Mercato NRAS, HRAS e KRAS), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72672
Our More Reports:
Plaque Psoriasis in 68 Market
https://exactitudeconsultancy.com/reports/73643/plaque-psoriasis-in-68-market
Parkinson's Disease Market
https://exactitudeconsultancy.com/reports/73645/parkinson-s-disease-market
Parkinson's Disease in 68 Market
https://exactitudeconsultancy.com/reports/73647/parkinson-s-disease-in-68-market
Amyotrophic Lateral Sclerosis Clinical Market
https://exactitudeconsultancy.com/reports/73649/amyotrophic-lateral-sclerosis-clinical-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NRAS, HRAS, and KRAS Market to Reach USD 14.1 Billion by 2034, Growing at a CAGR of 9.2% here
News-ID: 4299072 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for NRAS
NRAS/HRAS/KRAS market is projected to reach around USD 12.7 billion by 2034
Among the most infamous oncogenes in cancer biology, the RAS family-particularly NRAS, HRAS, and KRAS-has long been considered "undruggable." Yet in recent years, breakthroughs in targeted inhibitors, allele-specific therapies, and combination strategies are transforming this domain. The NRAS / HRAS / KRAS market is emerging as one of the pivotal battlegrounds in precision oncology, with enormous potential to reshape cancer treatment paradigms across multiple tumor types.
Download Full PDF Sample Copy…
NRAS, HRAS, and KRAS Market Targeting Key Oncogenes in the Era of Precision Medi …
Introduction
The RAS gene family - comprising NRAS, HRAS, and KRAS - plays a pivotal role in regulating cell proliferation, differentiation, and survival. Mutations in these oncogenes are among the most common drivers of cancer, particularly in lung, colorectal, pancreatic, and melanoma cases. Of the three, KRAS mutations are the most prevalent, accounting for a significant percentage of cancers worldwide, while NRAS and HRAS mutations, though less common, are equally critical…
RAS-Targeting Drugs for Precision Oncology Market Detailed Analysis with Accurat …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global RAS-Targeting Drugs for Precision Oncology Market Size, Share & Trends Analysis Report By Drug Type (Small Molecule Inhibitors, Biologics, RNA-Based Therapies, Combination Therapies), Target Mutation (KRAS G12C, KRAS G12D, KRAS G12V, G12R, G12S, G12A, HRAS and NRAS, Pan-RAS), Indication (Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Other Cancers (e.g., HNSCC,…
RAS-Targeting Drugs for Precision Oncology Market Driven by High Prevalence of R …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global RAS-Targeting Drugs for Precision Oncology Market Size, Share & Trends Analysis Report By Drug Type (Small Molecule Inhibitors, Biologics, RNA-Based Therapies, Combination Therapies), Target Mutation (KRAS G12C, KRAS G12D, KRAS G12V, G12R, G12S, G12A, HRAS and NRAS, Pan-RAS), Indication (Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Other Cancers (e.g., HNSCC,…
EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung …
The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable.
Amoy Diagnostics, located in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting…
NATIONAL COMPANY MARKS WORLD ARTHRITIS DAY
To mark World Arthritis Day (12th October 2011), a leading British bathing solutions manufacturer has teamed up with the National Rheumatoid Arthritis Society (NRAS) to help people understand what it really is like to suffer with arthritis, a condition that effects over 10 million people in the UK both young and old, 680,000 of which have rheumatoid arthritis.
National company Care in Bathing, which provides a range of bathing solutions for…
